Entasis: Innoviva's Acquisition of Entasis Therapeutics
Willkie Farr & Gallagher advised Innoviva on the transaction. Innoviva, Inc., a diversified holding company with a portfolio of royalties and a growing portfolio of innovative [...]
Read full article »
Entasis is a biotechnology company that develops and commercializes antibiotic therapies for the treatment of bacterial infections.
Read more